ClassID:

94837

C07D285/36 - CPC Classification

Classification description:

Heterocyclic compounds containing rings having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by groups  -  Seven-membered rings

Recent Application in this class:
#1
20260146032
2026-05-28

BENZOTHIA(DI)AZEPINE COMPOUNDS AND THEIR USE AS BILE ACID MODULATORS

#2
20250333390
2025-10-30

BENZOTHIA(DI)AZEPINE COMPOUNDS AND THEIR USE AS BILE ACID MODULATORS

#3
20250326728
2025-10-23

BENZOTHIADIAZEPINE COMPOUNDS AND THEIR USE AS BILE ACID MODULATORS

#4
20250304542
2025-10-02

Fused Heterobicyclic Antiviral Agents

#5
20250282808
2025-09-11

BILE ACID RECYCLING INHIBITORS FOR TREATMENT OF HYPERCHOLEMIA AND CHOLESTATIC LIVER DISEASE

#6
20250206714
2025-06-26

COMPOSITIONS AND METHODS FOR TREATMENT OF INFLAMMATORY DISEASES

#7
20250163009
2025-05-22

BENZOTHIA(DIA)ZEPINE COMPOUNDS FOR TREATMENT OF HBV AND HDV

#8
20250100983
2025-03-27

BENZOTHIA(DI)AZEPINE COMPOUNDS AND THEIR USE AS BILE ACID MODULATORS

#9
20250019354
2025-01-16

Crystal Modifications of Odevixibat

#10
20250019353
2025-01-16

BENZOTHIA(DI)AZEPINE COMPOUNDS AND THEIR USE AS BILE ACID MODULATORS

#11
20250019352
2025-01-16

PHARMACOLOGICAL AGENTS FOR TREATING OPHTHALMIC DISEASES

#12
20240368096
2024-11-07

Fused Heterobicyclic Antiviral Agents

#13
20240140922
2024-05-02

FUSED HETEROBICYCLIC ANTIVIRAL AGENTS

#14
20240109854
2024-04-04

Benzothia(di)azepine compounds and their use as bile acid modulators

#15
20240092748
2024-03-21

PHARMACEUTICAL FORMULATION OF ODEVIXIBAT

#16
20240067617
2024-02-29

BENZOTHIA(DI)AZEPINE COMPOUNDS AND THEIR USE AS BILE ACID MODULATORS

#17
20240065990
2024-02-29

METHODS, COMPOUNDS, COMPOSITIONS AND VEHICLES FOR DELIVERING 3-AMINO-1-PROPANESULFONIC ACID

#18
20230406832
2023-12-21

Benzothiadiazepine compounds and their use as bile acid modulators

#19
20230399324
2023-12-14

AGENTS FOR TREATING DISORDERS INVOLVING RYANODINE RECEPTORS

#20
20230250073
2023-08-10

Benzothia(di)azepine compounds and their use as bile acid modulators

#21
20230212211
2023-07-06

Bile acid recycling inhibitors for treatment of hypercholemia and cholestatic liver disease

#22
20230049950
2023-02-16

Benzothia(di)azepine compounds and their use as bile acid modulators

#23
20230024859
2023-01-26

Compounds and compositions for treating conditions associated with NLRP activity

#24
20220402885
2022-12-22

BENZOTHIA(DI)AZEPINE COMPOUNDS AND THEIR USE AS BILE ACID MODULATORS

#25
20220281832
2022-09-08

Crystal modifications of odevixibat

#26
20220162176
2022-05-26

Benzothia(di)azepine compounds and their use as bile acid modulators

#27
20220041568
2022-02-10

Benzothia(di)azepine compounds and their use as bile acid modulators

#28
20220020934
2022-01-20

5,6-DIPHENYL-5,6-DIHYDRO-DIBENZ[C,E][1,2]AZAPHOSPHORIN AND 6-PHENYL-6H-DIBENZO[C,E][1,2]THIAZIN-5,5-DIOXIDE DERIVATIVES AND SIMILAR COMPOUNDS AS ORGANIC ELECTROLUMINESCENT MATERIALS FOR OLEDS

#29
20210387956
2021-12-16

Benzothia(di)azepine compounds and their use as bile acid modulators

#30
20210386693
2021-12-16

METHODS, COMPOUNDS, COMPOSITIONS AND VEHICLES FOR DELIVERING 3-AMINO-1-PROPANESULFONIC ACID

#31
20210236511
2021-08-05

Pharmaceutical formulation of odevixibat

#32
20210179572
2021-06-17

Benzothiadiazepine compounds and their use as bile acid modulators

#33
20210171483
2021-06-10

Benzothiadiazepine compounds and their use as bile acid modulators

#34
20210171482
2021-06-10

Benzothia(di)azepine compounds and their use as bile acid modulators

#35
20210171481
2021-06-10

Benzothia(di)azepine compounds and their use as bile acid modulators

#36
20210171480
2021-06-10

Benzothia(di)azepine compounds and their use as bile acid modulators

#37
20210024475
2021-01-28

Crystal modifications of odevixibat

#38
20210017141
2021-01-21

Benzothia(di)azepine compounds and their use as bile acid modulators

#39
20200253897
2020-08-13

Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid

#40
20200247769
2020-08-06

Benzothiadiazepine compounds and their use as bile acid modulators

#41
20200207797
2020-07-02

BILE ACID RECYCLING INHIBITORS FOR TREATMENT OF HYPERCHOLEMIA AND CHOLESTATIC LIVER DISEASE

#42
20200062781
2020-02-27

Bisaryl heterocycles as NRF2 activators

#43
20200009086
2020-01-09

Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid

#44
20200002299
2020-01-02

Crystal modifications of odevixibat

#45
20190367467
2019-12-05

Benzothia(di)azepine compounds and their use as bile acid modulators

#46
20190169217
2019-06-06

BILE ACID RECYCLING INHIBITORS FOR TREATMENT OF HYPERCHOLEMIA AND CHOLESTATIC LIVER DISEASE

#47
20180362543
2018-12-20

HIV REPLICATION INHIBITOR

#48
20180170888
2018-06-21

Bicyclic tetrahydrothiazepine derivatives useful for the treatment of neoplastic and/or infectious diseases

#49
20170247368
2017-08-31

Fatty acid conjugates of quetiapine, process for making and using the same

#50
20170095430
2017-04-06

Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid

#51
20170037056
2017-02-09

Iminothiadiazepane dioxide compounds as BACE inhibitors, compositions, and their use

#52
20140323412
2014-10-30

BILE ACID RECYCLING INHIBITORS FOR TREATMENT OF HYPERCHOLEMIA AND CHOLESTATIC LIVER DISEASE

#53
20140275032
2014-09-18

Aryl sulfamide and sulfamate derivatives as RORc modulators

#54
20140220122
2014-08-07

Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid

#55
20140199601
2014-07-17

Additive for nonaqueous electrolyte, nonaqueous electrolyte, and electricity storage device

#56
20140120233
2014-05-01

Method for Producing Lanthionine Derivative

#57
20140088171
2014-03-27

Agents for treating disorders involving modulation of ryanodine receptors

#58
20140058097
2014-02-27

Pharmaceutical composition for treating alzheimer's disease

#59
20140024636
2014-01-23

Sulfamide derivative having an adamantyl group and its pharmaceutically acceptable salt

#60
20140011988
2014-01-09

Dibenzo[b,f][1,4]oxazepin-11-yl-N-hydroxybenzamides as HDAC inhibitors

#61
20130281512
2013-10-24

AGENTS FOR TREATING DISORDERS INVOLVING MODULATION OF RYANODINE RECEPTORS

#62
20130108573
2013-05-02

Bile Acid Recycling Inhibitors for Treatment of Hypercholemia and Cholestatic Liver Disease

#63
20130065114
2013-03-14

POLYMER ELECTROLYTE, MANUFACTURING METHOD FOR POLYMER ELECTROLYTE, IMIDE MONOMER, AND BATTERY

#64
20130045247
2013-02-21

Fatty acid conjugates of quetiapine, process for making and using the same

#65
20120329731
2012-12-27

THERAPEUTIC METHODS, COMPOSITIONS, AND COMPOUNDS

#66
20120252784
2012-10-04

2,3,4-BENZOTHIADIAZEPINE-2,2-DIOXIDE DERIVATIVES

#67
20120114588
2012-05-10

IBAT INHIBITORS FOR TREATMENT OF METABOLIC DISORDERS AND RELATED CONDITIONS

#68
20120015925
2012-01-19

NOVEL BENZOTHIAZEPINE AND BENZOTHIEPINE COMPOUNDS

#69
20110223207
2011-09-15

Fatty Acid Conjugates of Quetiapine, Process for Making and Using the Same

#70
20110196147
2011-08-11

INHIBITORS OF HISTONE DEACETYLASE

#71
20100240635
2010-09-23

Benzothiadiazepine compounds, a process for their preparation and pharmaceutical compositions containing them

#72
20100160290
2010-06-24

Pharmaceutical composition for treating Alzheimer's disease

#73
20100016282
2010-01-21

Heterocyclyl compounds

#74
20090197865
2009-08-06

THERAPEUTIC METHODS, COMPOSITIONS AND COMPOUNDS

#75
20080275023
2008-11-06

N-Hydroxyamides Omege-Substituted with Tricyclic Groups as Histone Deacetylase Inhibitors, Their Preparation and Use in Pharmaceutical Formulations

#76
20080207590
2008-08-28

Dibenzo[b,f][1,4]oxazepin-11-yl-N-hydroxybenzamides as HDAC inhibitors

#77
20080146642
2008-06-19

Methods, compounds, compositions and vehicles for delivering 3-amino-1-propanesulfonic acid

#78
20070190041
2007-08-16

Benzothiazepine and benzothiepine compounds

#79
20060063927
2006-03-23

Processes for preparing quetiapine and salts thereof

#80
20050256173
2005-11-17

Heterocyclic fluoroalkenyl thioethers and the use thereof as pesticides (I)

#81
20050143368
2005-06-30

Benzothiadiazepine derivatives, processes for their preparation and pharmaceutical compositions containing them

#82
20050080072
2005-04-14

Process for the preparation of a thiazepine derivative

#83
20050038009
2005-02-17

Benzothiazepine and benzothiazepine derivatives with ileal bile acid transport (IBAT) inhibotory activity for the treatment hyperlipidaemia

#84
20050009755
2005-01-13

Benzene-fused heteroring derivatives and pharmaceutical agents comprising the same as active ingredient